Gliotoxin Inhibits Proliferation and Induces Apoptosis in Colorectal Cancer Cells. 2015

Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
Guangdong Institute of Gastroenterology and the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, Guangdong, China. junxiong_ch@sina.com.

The discovery of new bioactive compounds from marine natural sources is very important in pharmacological research. Here we developed a Wnt responsive luciferase reporter assay to screen small molecule inhibitors of cancer associated constitutive Wnt signaling pathway. We identified that gliotoxin (GTX) and some of its analogues, the secondary metabolites from marine fungus Neosartorya pseufofischeri, acted as inhibitors of the Wnt signaling pathway. In addition, we found that GTX downregulated the β-catenin levels in colorectal cancer cells with inactivating mutations of adenomatous polyposis coli (APC) or activating mutations of β-catenin. Furthermore, we demonstrated that GTX induced growth inhibition and apoptosis in multiple colorectal cancer cell lines with mutations of the Wnt signaling pathway. Together, we illustrated a practical approach to identify small-molecule inhibitors of the Wnt signaling pathway and our study indicated that GTX has therapeutic potential for the prevention or treatment of Wnt dependent cancers and other Wnt related diseases.

UI MeSH Term Description Entries
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D011125 Adenomatous Polyposis Coli A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood. Polyposis Coli, Familial,Polyposis Syndrome, Familial,Adenomatous Polyposis Coli, Familial,Adenomatous Polyposis of the Colon,Familial Adenomatous Polyposis,Familial Adenomatous Polyposis Coli,Familial Adenomatous Polyposis of the Colon,Familial Intestinal Polyposis,Familial Multiple Polyposi,Familial Multiple Polyposis,Familial Multiple Polyposis Syndrome,Familial Polyposis Coli,Familial Polyposis Syndrome,Familial Polyposis of the Colon,Hereditary Polyposis Coli,Myh-Associated Polyposis,Polyposis Coli,Polyposis, Adenomatous Intestinal,Adenomatous Intestinal Polyposes,Adenomatous Intestinal Polyposis,Adenomatous Polyposes, Familial,Adenomatous Polyposis Colus,Adenomatous Polyposis, Familial,Coli, Adenomatous Polyposis,Coli, Familial Polyposis,Coli, Hereditary Polyposis,Coli, Polyposis,Colus, Adenomatous Polyposis,Colus, Familial Polyposis,Colus, Hereditary Polyposis,Colus, Polyposis,Familial Adenomatous Polyposes,Familial Intestinal Polyposes,Familial Multiple Polyposes,Familial Multiple Polyposus,Familial Polyposis Colus,Familial Polyposis Syndromes,Hereditary Polyposis Colus,Intestinal Polyposes, Familial,Intestinal Polyposis, Adenomatous,Intestinal Polyposis, Familial,Multiple Polyposes, Familial,Multiple Polyposi, Familial,Multiple Polyposis, Familial,Multiple Polyposus, Familial,Myh Associated Polyposis,Myh-Associated Polyposes,Polyposes, Familial Adenomatous,Polyposes, Familial Multiple,Polyposes, Myh-Associated,Polyposi, Familial Multiple,Polyposis Coli, Adenomatous,Polyposis Coli, Hereditary,Polyposis Colus,Polyposis Colus, Adenomatous,Polyposis Colus, Familial,Polyposis Colus, Hereditary,Polyposis, Familial Adenomatous,Polyposis, Familial Multiple,Polyposis, Myh-Associated,Polyposus, Familial Multiple
D005912 Gliotoxin A fungal toxin produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium. It is used as an immunosuppressive agent. Aspergillin,Gliotoxins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045325 HCT116 Cells Human COLORECTAL CARCINOMA cell line. HCT 116 Cells,HCT-116 Cells,Cell, HCT 116,Cell, HCT-116,Cell, HCT116,Cells, HCT 116,Cells, HCT-116,Cells, HCT116,HCT 116 Cell,HCT-116 Cell,HCT116 Cell
D051176 beta Catenin A multi-functional catenin that participates in CELL ADHESION and nuclear signaling. Beta catenin binds CADHERINS and helps link their cytoplasmic tails to the ACTIN in the CYTOSKELETON via ALPHA CATENIN. It also serves as a transcriptional co-activator and downstream component of WNT PROTEIN-mediated SIGNAL TRANSDUCTION PATHWAYS. beta-Catenin,Catenin, beta
D055326 Neosartorya A genus of ascomycetous fungi in the family Trichocomaceae, order EUROTIALES. Some species can cause opportunistic infections in humans, similar to its anamorph ASPERGILLUS. Neosartoryas

Related Publications

Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
March 2018, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
January 2020, Pharmacology,
Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
June 2018, Oncology letters,
Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
May 2009, Cancer letters,
Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
January 2013, Asian Pacific journal of cancer prevention : APJCP,
Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
February 2002, British journal of cancer,
Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
April 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
November 2003, International journal of cancer,
Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
January 2015, American journal of translational research,
Junxiong Chen, and Chenliang Wang, and Wenjian Lan, and Chunying Huang, and Mengmeng Lin, and Zhongyang Wang, and Wanling Liang, and Aikichi Iwamoto, and Xiangling Yang, and Huanliang Liu
January 2015, International journal of clinical and experimental pathology,
Copied contents to your clipboard!